These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31087217)

  • 21. Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.
    Korecka JA; Verhaagen J; Hol EM
    Regen Med; 2007 Jul; 2(4):425-46. PubMed ID: 17635050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and biochemical features in Alzheimer's disease.
    Pallàs M; Camins A
    Curr Pharm Des; 2006; 12(33):4389-408. PubMed ID: 17105434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging.
    Cogram P; Garduño BM; Ren B; Xu X
    J Alzheimers Dis; 2024; 98(1):333-336. PubMed ID: 38393919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerating Alzheimer's research through 'natural' animal models.
    Braidy N; Poljak A; Jayasena T; Mansour H; Inestrosa NC; Sachdev PS
    Curr Opin Psychiatry; 2015 Mar; 28(2):155-64. PubMed ID: 25602247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.
    Ittner LM; Klugmann M; Ke YD
    Br J Pharmacol; 2019 Sep; 176(18):3649-3665. PubMed ID: 30817847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem Cell Technology for (Epi)genetic Brain Disorders.
    Riemens RJM; Soares ES; Esteller M; Delgado-Morales R
    Adv Exp Med Biol; 2017; 978():443-475. PubMed ID: 28523560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dogs with cognitive dysfunction syndrome: a natural model of Alzheimer's disease.
    Bosch MN; Pugliese M; Gimeno-Bayón J; Rodríguez MJ; Mahy N
    Curr Alzheimer Res; 2012 Mar; 9(3):298-314. PubMed ID: 21875411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy.
    Derakhshankhah H; Sajadimajd S; Jafari S; Izadi Z; Sarvari S; Sharifi M; Falahati M; Moakedi F; Muganda WCA; Müller M; Raoufi M; Presley JF
    Nanomedicine; 2020 Feb; 24():102149. PubMed ID: 31927133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's Disease: Mechanism and Approach to Cell Therapy.
    Amemori T; Jendelova P; Ruzicka J; Urdzikova LM; Sykova E
    Int J Mol Sci; 2015 Nov; 16(11):26417-51. PubMed ID: 26556341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease.
    McGinley LM; Sims E; Lunn JS; Kashlan ON; Chen KS; Bruno ES; Pacut CM; Hazel T; Johe K; Sakowski SA; Feldman EL
    Stem Cells Transl Med; 2016 Mar; 5(3):379-91. PubMed ID: 26744412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?
    Raikwar SP; Thangavel R; Dubova I; Ahmed ME; Selvakumar PG; Kempuraj D; Zaheer S; Iyer S; Zaheer A
    J Alzheimers Dis; 2018; 65(2):321-344. PubMed ID: 30040732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.
    Van Dam D; Vloeberghs E; Abramowski D; Staufenbiel M; De Deyn PP
    CNS Spectr; 2005 Mar; 10(3):207-22. PubMed ID: 15744222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases.
    Youssef SA; Capucchio MT; Rofina JE; Chambers JK; Uchida K; Nakayama H; Head E
    Vet Pathol; 2016 Mar; 53(2):327-48. PubMed ID: 26869150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
    Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
    Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of animal models for therapy of Alzheimer's disease].
    Shoji M
    Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):27-9. PubMed ID: 12649842
    [No Abstract]   [Full Text] [Related]  

  • 37. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.
    Götz J; Streffer JR; David D; Schild A; Hoerndli F; Pennanen L; Kurosinski P; Chen F
    Mol Psychiatry; 2004 Jul; 9(7):664-83. PubMed ID: 15052274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Emerging Therapeutic Role of NGF in Alzheimer's Disease.
    Xu CJ; Wang JL; Jin WL
    Neurochem Res; 2016 Jun; 41(6):1211-8. PubMed ID: 26801170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice.
    Ma T; Gong K; Ao Q; Yan Y; Song B; Huang H; Zhang X; Gong Y
    Cell Transplant; 2013; 22 Suppl 1():S113-26. PubMed ID: 24070198
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.